ALEMBIC PHARMACEUTICALS LTD.

NSE : APLLTDBSE : 533573ISIN CODE : INE901L01018Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE990.65-4.4 (-0.44 %)
PREV CLOSE ( ) 995.05
OPEN PRICE ( ) 1014.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3810
TODAY'S LOW / HIGH ( )986.00 1014.95
52 WK LOW / HIGH ( )536.6 1093.05
NSE990.25-7.25 (-0.73 %)
PREV CLOSE( ) 997.50
OPEN PRICE ( ) 1002.50
BID PRICE (QTY) 990.25 (191)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 274350
TODAY'S LOW / HIGH( ) 986.75 1010.70
52 WK LOW / HIGH ( )542.4 1094

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.